Endolumenal Fundoplication With EsophyX: The Initial North American Experience

September 2008
Surgical Innovation;Sep2008, Vol. 15 Issue 3, p166
Academic Journal
No abstract available.


Related Articles

  • Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population. Demyttenaere, Sebastian V.; Bergman, Simon; Pham, Thomas; Anderson, Joel; Dettorre, Rebecca; Melvin, W.; Mikami, Dean J. // Surgical Endoscopy;Apr2010, Vol. 24 Issue 4, p854 

    EsophyX is an endolumenal approach to the treatment of gastroesophageal reflux disease (GERD). This report describes one of the earliest and largest North American experiences with this device. Prospective data were gathered on consecutive patients undergoing EsophyX fundoplication for a 1-year...

  • HEALTH BEAT. RAVITS, SARAH // New Orleans Magazine;Oct2011, p39 

    The article offers information on the EsophyX TIF procedure offered by Ocshner North Shore surgeons, the annual Susan G Komen Race for the Cure® on October 22, 2012 at City Park in New Orleans, Louisiana, and the study of Louisiana State University (LSU) Health Sciences Center on diabetes.

  • EndoGastric Solutions Raises $13 Mln in Additional Funding.  // Biomedical Market Newsletter;6/25/2012, Vol. 21, p1 

    The article offers information related to an announcement made by EndoGastric Solutions Inc. (EGS) regarding completion of its additional funding. Mike Carusi, partner, Advanced Technology Ventures, states that EGS technology has potential to address millions of patients suffering from chronic...

  • First Patient Enrolled and Treated in the U.S. for EndoGastric Solutions' Randomized Study of Transoral Incisionless Fundoplication (TIF(r)).  // Biomedical Market Newsletter;6/30/2011, p198 

    The article reports on the announcement of EndoGastric Solutions (EGS) Inc. that the first patient has been enrolled and treated in the Randomized EsophyX vs. Sham/Placebo Controlled Trial (RESPECT) study in the U.S. It states that the RESPECT study was designed to generate the first level...

  • Comprehensive evaluation of endoscopic fundoplication using the EsophyX device. Petersen, Rebecca; Filippa, Laura; Wassenaar, Eelco; Martin, Ana; Tatum, Roger; Oelschlager, Brant // Surgical Endoscopy;Apr2012, Vol. 26 Issue 4, p1021 

    Background: There are limited studies that evaluate the efficacy of endoscopic fundoplication (EF) for gastroesophageal reflux disease (GERD) with the EsophyX device, especially with the most recent procedural iteration (TIF-2). This study was a prospective evaluation of our early experience...

  • PRODUCT BRIEFS.  // Medical Device Daily;2/27/2008, Vol. 12 Issue 39, p12 

    This section offers news briefs on the U.S. medical device industry. Artificial Medical Intelligence's EMscribe Dx hospital coding system has a new add-on module to the inpatient portion of the system. The one-year follow-up on GERD patients in the Phase II multi-center study of EndoGastric...

  • Antireflux Transoral Incisionless Fundoplication Using EsophyX: 12-Month Results of a Prospective Multicenter Study. Cadière, Guy-Bernard; Buset, Michel; Muls, Vinciane; Rajan, Amin; Rösch, Thomas; Eckardt, Alexander; Weerts, Joseph; Bastens, Boris; Costamagna, Guido; Marchese, Michele; Louis, Hubert; Mana, Fazia; Sermon, Filip; Gawlicka, Anna K.; Daniel, Michael A.; Devière, Jacques // World Journal of Surgery;Aug2008, Vol. 32 Issue 8, p1676 

    A novel transoral incisionless fundoplication (TIF) procedure using the EsophyX system with SerosaFuse fasteners was designed to reconstruct a full-thickness valve at the gastroesophageal junction through tailored delivery of multiple fasteners during a single-device insertion. The safety and...

  • Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Bell, Reginald C. W.; Cadière, Guy-Bernard // Surgical Endoscopy;Jul2011, Vol. 25 Issue 7, p2387 

    Background: Gastroesophageal reflux disease (GERD) results primarily from the loss of an effective antireflux barrier, which forms a mechanical barrier against the retrograde movement of gastric content. Restoration of the incompetent antireflux barrier is possible by longitudinal and rotational...

  • Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Testoni, Pier; Vailati, Cristian; Testoni, Sabrina; Corsetti, Maura // Surgical Endoscopy;May2012, Vol. 26 Issue 5, p1425 

    Introduction: Transoral incisionless fundoplication (TIF) with the EsophyX device is reported to be effective for creating a continent gastroesophageal valve and for good functional results, as measured by pH impedance in patients with gastroesophageal reflux disease (GERD). The aim of this...

  • Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Bell, Reginald; Freeman, Katherine // Surgical Endoscopy;Jun2011, Vol. 25 Issue 6, p1975 

    Background: Transoral treatment of gastroesophageal reflux disease (GERD) using the EsophyX device enables creation of an esophagogastric fundoplication with potential for better control of reflux than gastrogastric techniques. Efficacy and safety of a rotational/longitudinal esophagogastric...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics